Integration-deficient Lentiviral Vectors: A Slow Coming of Age
Open accessAbstract
Lentiviral vectors are very efficient at transducing dividing and quiescent cells, which makes them highly useful tools for genetic analysis and gene therapy. Traditionally this efficiency was considered dependent on provirus integration in the host cell genome; however, recent results have challenged this view. So called integration-deficient lentiviral vectors (IDLVs) can be produced through the use of integrase mutations that specifically prevent proviral integration, resulting in the generation of increased levels of circular vector episomes in transduced cells. These lentiviral episomes lack replication signals and are gradually lost by dilution in dividing cells, but are stable in quiescent cells. Compared to integrating lentivectors, IDLVs have a greatly reduced risk of causing insertional mutagenesis and a lower risk of generating replication-competent recombinants (RCRs). IDLVs can mediate transient gene expression in proliferating cells, stable expression in nondividing cells in vitro and in vivo, specific immune responses, RNA interference, homologous recombination (gene repair, knock-in, and knock-out), site-specific recombination, and transposition. IDLVs can be converted into replicating episomes, suggesting that if a clinically applicable system can be developed they would also become highly appropriate for stable transduction of proliferating tissues in therapeutic applications.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
NILVs are still the best option for quiescent cells.
“Thus, NILVs are still the best option for quiescent cells, as critically summarised in one review paper [75].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [75]
Different mutation sites of the integrase plasmid resulted in different gene expression levels.
“This approach could help to increase the episomal gene expression, as reported in a previous study where different mutation sites of the integrase plasmid resulted in different gene expression levels [75].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [75]
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221 · see citing works
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903 · see citing works
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341 · see citing works
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145 · see citing works
Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain.
Kim, Y. G., Cha, J., & Chandrasegaran, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1156 · Cited by 2,099 · see citing works
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977 · see citing works
Effect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924 · see citing works
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.-L., Fraser, C. C., Cavazzana-Calvo, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejm200301163480314 · Cited by 1,867 · see citing works
Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery
Zufferey, R., Dull, T., Mandel, R. J., Bukovsky, A., Quiroz, D., Naldini, L., & Trono, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9873-9880.1998 · Cited by 1,815 · see citing works
An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C. C., Horn, S. T., Muna, M., Ng, L., Nye, J. A., Sampson-Johannes, A., Fattaey, A., et al. (1996) · Science · doi:10.1126/science.274.5286.373 · Cited by 1,753 · see citing works
Highly efficient endogenous human gene correction using designed zinc-finger nucleases
Urnov, F. D., Miller, J. C., Lee, Y.-L., Beausejour, C. M., Rock, J. M., Augustus, S., Jamieson, A. C., Porteus, M. H., Gregory, P. D., & Holmes, M. C. (2005) · Nature · doi:10.1038/nature03556 · Cited by 1,642 · see citing works
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gönczöl, É., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4407 · Cited by 1,574 · see citing works
Naldini, L., Blömer, U., Gage, F. H., Trono, D., & Verma, I. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11382 · Cited by 1,499 · see citing works
Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin
Hanna, J. H., Wernig, M., Markoulaki, S., Sun, C., Meissner, A., Cassady, J. P., Beard, C., Brambrink, T., Wu, L.-C., Townes, T. M., et al. (2007) · Science · doi:10.1126/science.1152092 · Cited by 1,493 · see citing works
Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells
Yates, J. L., Warren, N., & Sugden, B. (1985) · Nature · doi:10.1038/313812a0 · Cited by 1,305 · see citing works
Development of a self-inactivating lentivirus vector
Miyoshi, H., Blömer, U., Takahashi, M., Gage, F. H., & Verma, I. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8150-8157.1998 · Cited by 1,196 · see citing works
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
Perez, E. E., Wang, J., Miller, J. C., Jouvenot, Y., Kim, K. A., Liu, O., Wang, N., Lee, G., Bartsevich, V. V., Lee, Y.-L., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1410 · Cited by 999 · see citing works
The accuracy of reverse transcriptase from HIV-1
Roberts, J. D., Bebenek, K., & Kunkel, T. A. (1988) · Science · doi:10.1126/science.2460925 · Cited by 997 · see citing works
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954 · see citing works
Follenzi, A., Ailles, L., Bakovic, S., Geuna, M., & Naldini, L. (2000) · Nature Genetics · doi:10.1038/76095 · Cited by 926 · see citing works
HIV-1: Fifteen Proteins and an RNA
Frankel, A. D., & Young, J. A. T. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.1 · Cited by 913 · see citing works
HIV-1 genome nuclear import is mediated by a central DNA flap.
Zennou, V., Petit, C., Guétard, D., Nerhbass, U., Montagnier, L., & Charneau, P. (2000) · Cell · doi:10.1016/s0092-8674(00)80828-4 · Cited by 893 · see citing works
Lombardo, A., Genovese, P., Beausejour, C. M., Colleoni, S., Lee, Y.-L., Kim, K. A., Ando, D., Urnov, F. D., Galli, C., Gregory, P. D., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1353 · Cited by 845 · see citing works
Cd8(+) T-Cell Responses to Adeno-Associated Virus Capsid in Humans
Mingozzi, F., Maus, M. V., Hui, D. J., Sabatino, D. E., Murphy, S. L., Rasko, J. E. J., Ragni, M. V., Manno, C. S., Sommer, J., Jiang, H., et al. (2007) · Nature Medicine · doi:10.1038/nm1549 · Cited by 748 · see citing works
Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector
Blömer, U., Naldini, L., Kafri, T., Trono, D., Verma, I. M., & Gage, F. H. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6641-6649.1997 · Cited by 725 · see citing works
Immune responses to adenovirus and adeno-associated virus in humans
Chirmule, N., Propert, K. J., Magosin, S. A., Qian, Y., Qian, R., & Wilson, J. M. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300994 · Cited by 684 · see citing works
A quantitative assay for HIV DNA integration in vivo
Butler, S. L., Hansen, M. S., & Bushman, F. D. (2001) · Nature Medicine · doi:10.1038/87979 · Cited by 678 · see citing works
Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
Kafri, T., Blömer, U., Peterson, D. A., Gage, F. H., & Verma, I. M. (1997) · Nature Genetics · doi:10.1038/ng1197-314 · Cited by 604 · see citing works
Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells.
Yu, S. F., von Rüden, T., Kantoff, P. W., Garber, C., Seiberg, M., Rüther, U., Anderson, W. F., Wagner, E. F., & Gilboa, E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3194 · Cited by 541 · see citing works
Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector
Miyoshi, H., Takahashi, M., Gage, F. H., & Verma, I. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10319 · Cited by 494 · see citing works
Lin, F., Sperle, K., & Sternberg, N. L. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.6.1020-1034.1984 · Cited by 461 · see citing works
Effective gene therapy with nonintegrating lentiviral vectors
Yáñez-Muñoz, R. J., Balaggan, K. S., MacNeil, A., Howe, S. J., Schmidt, M., Smith, A. J., Buch, P., MacLaren, R. E., Anderson, P. N., Barker, S. E., et al. (2006) · Nature Medicine · doi:10.1038/nm1365 · Cited by 460 · see citing works
Self-citationChoulika, A., Perrin, A., Dujon, B., & Nicolas, J.-F. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.1968 · Cited by 459 · see citing works
Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication
Engelman, A., Englund, G., Orenstein, J. M., Martin, M. A., & Craigie, R. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.2729-2736.1995 · Cited by 445 · see citing works
Mazarakis, N. D. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.19.2109 · Cited by 425 · see citing works
Folger, K. R., Wong, E. A., Wahl, G. M., & Capecchi, M. R. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.11.1372-1387.1982 · Cited by 423 · see citing works
Markowitz, M. H., Nguyen, B., Gotuzzo, E., Mendo, F., Ratanasuwan, W., Kovacs, C. M., Prada, G., Morales-Ramirez, J. O., Crumpacker, C. S., Isaacs, R., et al. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318157131c · Cited by 408 · see citing works
Role of the non‐homologous DNA end joining pathway in the early steps of retroviral infection
Li, L., Olvera, J. M., Yoder, K., Mitchell, R., Butler, S., Lieber, M., Martin, S. L., & Bushman, F. D. (2001) · EMBO Journal · doi:10.1093/emboj/20.12.3272 · Cited by 386 · see citing works
Case, S. S., Price, M. A., Jordan, C. T., Yu, X. J., Wang, L., Bauer, G., Haas, D. L., Xu, D., Stripecke, R., Naldini, L., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2988 · Cited by 384 · see citing works
Shank, P. R., Hughes, S. H., Kung, H.-J., Majors, J. E., Quintrell, N. A., Guntaka, R. V., Bishop, J. M., & VARMUS, H. E. (1978) · Cell · doi:10.1016/0092-8674(78)90063-6 · Cited by 383 · see citing works
Silencing and Variegation of Gammaretrovirus and Lentivirus Vectors
Ellis, J. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1241 · Cited by 379 · see citing works
Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles
Reiser, J., Harmison, G. G., Kluepfel-Stahl, S., Brady, R. O., Karlsson, S., & Schubert, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15266 · Cited by 372 · see citing works
Zinc-finger Nucleases: The Next Generation Emerges.
Cathomen, T., & Joung, J. (2008) · Molecular Therapy · doi:10.1038/mt.2008.114 · Cited by 361 · see citing works
Gene delivery by lentivirus vectors
Cockrell, A. S., & Kafri, T. (2007) · Molecular Biotechnology · doi:10.1007/s12033-007-0010-8 · Cited by 358 · see citing works
Shimura, K., Kodama, E. N., Sakagami, Y., Matsuzaki, Y., Watanabe, W., Yamataka, K., Watanabe, Y., Ohata, Y., Doi, S., Sato, M., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01534-07 · Cited by 342 · see citing works
An Improved Plasmid DNA Expression Vector for Direct Injection into Skeletal Muscle
Hartikka, J., Sawdey, M., Cornefert-Jensen, F., Margalith, M., Barnhart, K. M., Nolasco, M., Vahlsing, H. L., Meek, J., Marquet, M., Hobart, P. M., et al. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.10-1205 · Cited by 328 · see citing works
Manipulating the mammalian genome by homologous recombination
Vásquez, K. M., Marburger, K., Intödy, Z., & Wilson, J. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111009698 · Cited by 303 · see citing works
Mali, P., Ye, Z., Hommond, H. H., Yu, X., Lin, J., Chen, G., Zou, J., & Cheng, L. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0346 · Cited by 291 · see citing works
The road to chromatin — nuclear entry of retroviruses
Suzuki, Y., & Craigie, R. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1579 · Cited by 288 · see citing works
Lentiviral-Mediated RNA Interference
Abbas‐Terki, T., Blanco-Bose, W. E., Déglon, N., Pralong, W. F., & Aebischer, P. (2002) · Human Gene Therapy · doi:10.1089/104303402320987888 · Cited by 284 · see citing works
RNAi Mechanisms and Applications
Kim, D. H., & Rossi, J. J. (2008) · BioTechniques · doi:10.2144/000112792 · Cited by 281 · see citing works
HIV Integrase, a Brief Overview from Chemistry to Therapeutics*
Craigie, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100027200 · Cited by 277 · see citing works
Stable gene transfer to the nervous system using a non-primate lentiviral vector
Mitrophanous, K. A., Yoon, S., Rohll, J. B., Patil, D., Wilkes, F. J., Kim, V. N., Kingsman, S. M., Kingsman, A. J., & Mazarakis, N. D. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301023 · Cited by 277 · see citing works
Physiological Promoters Reduce the Genotoxic Risk of Integrating Gene Vectors
Zychlinski, D., Schambach, A., Modlich, U., Maetzig, T., Meyer, J., Grassman, E., Mishra, A., & Baum, C. (2008) · Molecular Therapy · doi:10.1038/mt.2008.5 · Cited by 271 · see citing works
Wiskerchen, M. A., & Muesing, M. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.376-386.1995 · Cited by 271 · see citing works
Minimal Requirement for a Lentivirus Vector Based on Human Immunodeficiency Virus Type 1
Kim, V. N., Mitrophanous, K. A., Kingsman, S. M., & Kingsman, A. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.811-816.1998 · Cited by 269 · see citing works
A novel engineered meganuclease induces homologous recombination in yeast and mammalian cells
Epinat, J.-C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg375 · Cited by 264 · see citing works
Shoemaker, C. B., Goff, S. P., Gilboa, E., Paskind, M. P., Mitra, S. W., & Baltimore, D. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3932 · Cited by 259 · see citing works
LaFemina, R. L., Schneider, C. L., Robbins, H. L., Callahan, P. L., LeGrow, K., Roth, E., Schleif, W. A., & Emini, E. A. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.7414-7419.1992 · Cited by 257 · see citing works
Lentiviral vectors: regulated gene expression.
Kafri, T., van Praag, H., Gage, F. H., & Verma, I. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0083 · Cited by 251 · see citing works
Philippe, S., Sarkis, C., Barkats, M., Mammeri, H., Ladroue, C., Petit, C., Mallet, J., & Serguera, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606197103 · Cited by 249 · see citing works
Human Immunodeficiency Virus cDNA Metabolism: Notable Stability of Two-Long Terminal Repeat Circles
Butler, S. L., Johnson, E. P., & Bushman, F. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.3739-3747.2002 · Cited by 237 · see citing works
Leavitt, A. D., Robles, G., Alesandro, N., & Varmus, H. E. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.721-728.1996 · Cited by 232 · see citing works
Cell-surface expression of influenza haemagglutinin from a cloned DNA copy of the RNA gene
Gething, M.-J. H., & Sambrook, J. (1981) · Nature · doi:10.1038/293620a0 · Cited by 231 · see citing works
Brussel, A., & Sonigo, P. (2003) · Journal of Virology · doi:10.1128/jvi.77.18.10119-10124.2003 · Cited by 223 · see citing works
Double-strand breaks at the target locus stimulate gene targeting in embryonic stem cells
Smih, F., Rouet, P., Romanienko, P. J., & Jasin, M. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.24.5012 · Cited by 220 · see citing works
The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold
Humme, S., Reisbach, G., Feederle, R., Delecluse, H., Bousset, K., Hammerschmidt, W., & Schepers, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1832776100 · Cited by 214 · see citing works
Piechaczek, C., Fetzer, C., Baiker, A. E., Bode, J., & Lipps, H. J. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.2.426 · Cited by 211 · see citing works
Analysis of unintegrated avian RNA tumor virus double-stranded DNA intermediates
Hsu, T. W., Sabran, J. L., Mark, G. E., Guntaka, R. V., & Taylor, J. M. (1978) · Journal of Virology · doi:10.1128/jvi.28.3.810-818.1978 · Cited by 206 · see citing works
Hindmarsh, P. L., & Leis, J. P. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.4.836-843.1999 · Cited by 203 · see citing works
Brochériou, V., Hagège, A., Oubenaissa, A., Lambert, M., Mallet, V. O., Duriez, M., Wassef, M., Kahn, A., Menasché, P., & Gilgenkrantz, H. (2000) · Journal of Gene Medicine · doi:10.1002/1521-2254(200009/10)2:5 · Cited by 202 · see citing works
Transient Gene Expression by Nonintegrating Lentiviral Vectors
Nightingale, S. J., Hollis, R. P., Pepper, K. A., Petersen, D., Yu, X.-J., Yang, C., Bahner, I., & Kohn, D. B. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.008 · Cited by 192 · see citing works
Donehower, L. A., & Varmus, H. E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.20.6461 · Cited by 183 · see citing works
Pierson, T. C., Kieffer, T. L., Ruff, C. T., Buck, C. B., Gange, S. J., & Siliciano, R. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.4138-4144.2002 · Cited by 178 · see citing works
In Vivo Analysis of Retroviral Integrase Structure and Function
Engelman, A. (1999) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60309-7 · Cited by 176 · see citing works
Stable Gene Transfer to Muscle Using Non-integrating Lentiviral Vectors
Apolonia, L., Waddington, S. N., Fernandes, C., Ward, N. J., Bouma, G., Blundell, M. P., Thrasher, A. J., Collins, M. K., & Philpott, N. J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300281 · Cited by 174 · see citing works
Abordo‐Adesida, E., Follenzi, A., Barcia, C., Sciascia, S. A., Castro, M. G., Naldini, L., & Lowenstein, P. R. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.741 · Cited by 169 · see citing works
Panganiban, A. T., & Temin, H. M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7885 · Cited by 164 · see citing works
Yáñez‐Muñoz, R. J., & Porter, A. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300601 · Cited by 163 · see citing works
Self-citationRetrovirus vector silencing is de novo methylase independent and marked by a repressive histone code
Pannell, D., Osborne, C. S., Yao, S., Sukonnik, T., Pasceri, P., Karaiskakis, A., Okano, M., Li, E., Lipshitz, H. D., & Ellis, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5884 · Cited by 158 · see citing works
Therapeutic levels of human factor VIII and IX using HIV-1–based lentiviral vectors in mouse liver
Park, F., Ohashi, K., & Kay, M. A. (2000) · Blood · doi:10.1182/blood.v96.3.1173 · Cited by 157 · see citing works
Haas, D. L., Case, S. S., Crooks, G. M., & Kohn, D. B. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0094 · Cited by 153 · see citing works
Arnould, S., Perez, C., Cabaniols, J., Smith, J. N. P., Gouble, A., Grizot, S., Epinat, J.-C., Duclert, A., Duchateau, P. N., & Pâques, F. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.04.079 · Cited by 141 · see citing works
RNA 3′ Readthrough of Oncoretrovirus and Lentivirus: Implications for Vector Safety and Efficacy
Zaiss, A. K., Son, S., & Chang, L. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7209-7219.2002 · Cited by 135 · see citing works
The φC31 Integrase System for Gene Therapy
Calos, M. P. (2006) · Current Gene Therapy · doi:10.2174/156652306779010642 · Cited by 133 · see citing works
Novel Integrase-Defective Lentiviral Episomal Vectors for Gene Transfer
Vargas, J., Gusella, G. L., Najfeld, V., Klotman, M., & Cara, A. (2004) · Human Gene Therapy · doi:10.1089/104303404322959515 · Cited by 132 · see citing works
Improving Transcriptional Termination of Self-inactivating Gamma-retroviral and Lentiviral Vectors
Schambach, A., Galla, M., Maetzig, T., Loew, R., & Baum, C. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300152 · Cited by 127 · see citing works
Generation of a human X‐derived minichromosome using telomere‐associated chromosome fragmentation.
Farr, C. J., Bayne, R. A. L., Kipling, D., Mills, W. E., Critcher, R., & Cooke, H. J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00228.x · Cited by 126 · see citing works
HIV-1 gene expression: lessons from provirus and non-integrated DNA
Wu, Y. (2004) · Retrovirology · doi:10.1186/1742-4690-1-13 · Cited by 124 · see citing works
Arumugam, P. I., Scholes, J., Perelman, N., Xia, P., Yee, J., & Malik, P. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300259 · Cited by 124 · see citing works
Saenz, D. T., Loewen, N. A., Peretz, M., Whitwam, T., Barraza, R., Howell, K. G., Holmes, J. M., Good, M. S., & Poeschla, E. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2906-2920.2004 · Cited by 119 · see citing works
Development of Multigene and Regulated Lentivirus Vectors
Reiser, J., Lai, Z., Zhang, X., & Brady, R. O. (2000) · Journal of Virology · doi:10.1128/jvi.74.22.10589-10599.2000 · Cited by 119 · see citing works
Immunological Aspects of Recombinant Adeno-Associated Virus Delivery to the Mammalian Brain
Mastakov, M. Y., Baer, K., Symes, C. W., Leichtlein, C. B., Kotin, R. M., & During, M. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.16.8446-8454.2002 · Cited by 114 · see citing works
Ivics, Z., & Izsvák, Z. (2006) · Current Gene Therapy · doi:10.2174/156652306778520647 · Cited by 114 · see citing works
Capture of DNA Sequences at Double-Strand Breaks in Mammalian Chromosomes
Lin, Y., & Waldman, A. S. (2001) · Genetics · doi:10.1093/genetics/158.4.1665 · Cited by 113 · see citing works
The inner-nuclear-envelope protein emerin regulates HIV-1 infectivity
Jacqué, J.-M., & Stevenson, M. (2006) · Nature · doi:10.1038/nature04682 · Cited by 113 · see citing works
Hoshiya, H., Kazuki, Y., Abe, S., Takiguchi, M., Kajitani, N., Watanabe, Y., Yoshino, T., Shirayoshi, Y., Higaki, K., Messina, G., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.253 · Cited by 109 · see citing works
Zhang, X., Beard, B. C., Trobridge, G. D., Wood, B. L., Sale, G. E., Sud, R., Humphries, R. K., & Kiem, H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34371 · Cited by 108 · see citing works
Targeted Genome Modifications Using Integrase-deficient Lentiviral Vectors
Cornu, T. I., & Cathomen, T. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300345 · Cited by 105 · see citing works
In Vivo Evidence for Instability of Episomal Human Immunodeficiency Virus Type 1 cDNA
Sharkey, M. E., Triques, K., Kuritzkes, D. R., & Stevenson, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5203-5210.2005 · Cited by 105 · see citing works
Cannon, P. M., Wilson, W., Byles, E. D., Kingsman, S. M., & Kingsman, A. J. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.4768-4775.1994 · Cited by 104 · see citing works
Shimada, T., Fujii, H., Mitsuya, H., & Nienhuis, A. W. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115365 · Cited by 104 · see citing works
Effects of long terminal repeat mutations on human immunodeficiency virus type 1 replication
Lu, Y., Stenzel, M., Sodroski, J., & Haseltine, W. A. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.4115-4119.1989 · Cited by 102 · see citing works
Rahim, A. A., Wong, A. M. S., Howe, S. J., Buckley, S. M. K., Acosta-Saltos, A. D., Elston, K. E., Ward, N. J., Philpott, N. J., Cooper, J. D., Anderson, P. N., et al. (2009) · Gene Therapy · doi:10.1038/gt.2008.186 · Cited by 101 · see citing works
Diverse IgG subclass responses to adeno‐associated virus infection and vector administration
Murphy, S. L., Li, H., Mingozzi, F., Sabatino, D. E., Hui, D. J., Edmonson, S. A., & High, K. A. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21360 · Cited by 101 · see citing works
Murine leukemia virus: detection of unintegrated double-stranded DNA forms of the provirus.
Gianni, A., Smotkin, D., & Weinberg, R. A. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.2.447 · Cited by 100 · see citing works
Oncogenic potentials of the human polyomavirus regulatory proteins
Moens, U. L., Ghelue, M. V., & Johannessen, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7020-3 · Cited by 99 · see citing works
Miller, M. D., Wang, B., & Bushman, F. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3938-3944.1995 · Cited by 96 · see citing works
Hybrid Lentivirus-transposon Vectors with a Random Integration Profile in Human Cells
Staunstrup, N. H., Moldt, B., Mátés, L., Villesen, P., Jakobsen, M., Ivics, Z., Izsvák, Z., & Mikkelsen, J. G. (2009) · Molecular Therapy · doi:10.1038/mt.2009.10 · Cited by 96 · see citing works
A Large U3 Deletion Causes Increased In Vivo Expression from a Nonintegrating Lentiviral Vector
Bayer, M., Kantor, B., Cockrell, A., Ma, H., Zeithaml, B., Li, X., McCown, T., & Kafri, T. (2008) · Molecular Therapy · doi:10.1038/mt.2008.199 · Cited by 94 · see citing works
Evidence for Gene Expression by Unintegrated Human Immunodeficiency Virus Type 1 DNA Species
Brussel, A., & Sonigo, P. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11263-11271.2004 · Cited by 93 · see citing works
Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin
Li, S., Kimura, E., Fall, B. M., Reyes, M., Angello, J. C., Welikson, R. E., Hauschka, S. D., & Chamberlain, J. S. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302505 · Cited by 90 · see citing works
Use of Nonintegrating Lentiviral Vectors for Gene Therapy
Philpott, N. J., & Thrasher, A. J. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.013 · Cited by 88 · see citing works
Karwacz, K., Mukherjee, S., Apolonia, L., Blundell, M. P., Bouma, G., Escors, D., Collins, M. K., & Thrasher, A. J. (2009) · Journal of Virology · doi:10.1128/jvi.02519-08 · Cited by 87 · see citing works
Logan, A. C., Haas, D. L., Kafri, T., & Kohn, D. B. (2004) · Journal of Virology · doi:10.1128/jvi.78.16.8421-8436.2004 · Cited by 85 · see citing works
Successful Immunization with a Single Injection of Non-integrating Lentiviral Vector
Negri, D. R., Michelini, Z., Baroncelli, S., Spada, M., Vendetti, S., Buffa, V., Bona, R., Leone, P., Klotman, M. E., & Cara, A. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300241 · Cited by 84 · see citing works
Masuda, T., Kuroda, M. J., & Harada, S. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8396-8402.1998 · Cited by 83 · see citing works
Fabes, J., Anderson, P. N., Yáñez‐Muñoz, R. J., Thrasher, A. J., Brennan, C. H., & Bolsover, S. R. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04704.x · Cited by 83 · see citing works
Self-citationKawai, T., Choi, U., Cardwell, L., Ravin, S. S. D., Naumann, N., Whiting‐Theobald, N., Linton, G. F., Moon, J., Murphy, P. M., & Malech, H. L. (2006) · Blood · doi:10.1182/blood-2006-05-025296 · Cited by 81 · see citing works
Human Immunodeficiency Virus Type 1 Quasispecies In Vivo and Ex Vivo
Wain–Hobson, S. (1992) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-77011-1_12 · Cited by 79 · see citing works
HIV-1 Extrachromosomal 2-LTR Circular DNA Is Long-Lived in Human Macrophages
Gillim-Ross, L., Cara, A., & Klotman, M. E. (2005) · Viral Immunology · doi:10.1089/vim.2005.18.190 · Cited by 74 · see citing works
Non-Integrating Lentiviral Vectors
Sarkis, C., Philippe, S., Mallet, J. J., & Serguera, C. (2008) · Current Gene Therapy · doi:10.2174/156652308786848012 · Cited by 74 · see citing works
Al‐Mawsawi, L. Q., & Neamati, N. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.09.005 · Cited by 71 · see citing works
Cara, A., Cereseto, A., Lori, F., & Reitz, M. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5393 · Cited by 64 · see citing works
Seidman, M. M. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.10.3561 · Cited by 62 · see citing works
Gaur, M., & Leavitt, A. D. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.4678-4685.1998 · Cited by 52 · see citing works
Jenke, A., Scinteie, M. F., Stehle, I. M., & Lipps, H. J. (2004) · Molecular Biology Reports · doi:10.1023/b:mole.0000031363.35839.46 · Cited by 49 · see citing works
Jonsson, C. B., Donzella, G. A., Gaucan, E., Smith, C. M., & Roth, M. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4585-4597.1996 · Cited by 46 · see citing works
Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase
Moldt, B., Staunstrup, N. H., Jakobsen, M., Yáñez-Muñoz, R. J., & Mikkelsen, J. G. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-60 · Cited by 44 · see citing works
Self-citationRetroviral E-DNA: persistence and gene expression in nondividing immune cells
Cara, A., & Klotman, M. E. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306151 · Cited by 39 · see citing works
Site-specific nicking at the avian retrovirus LTR circle junction by the viral pp32 DNA endonuclease
Grandgenett, D. P., & Vora, A. C. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.17.6205 · Cited by 38 · see citing works
Lu, R. Q., Nakajima, N., Hofmann, W., Benkirane, M., Jeang, K., Sodroski, J., & Engelman, A. (2004) · Journal of Virology · doi:10.1128/jvi.78.2.658-668.2004 · Cited by 36 · see citing works
Loewen, N. A., Leske, D. A., Chen, Y., Teo, W., Saenz, D. T., Peretz, M., Holmes, J. M., & Poeschla, E. M. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.447 · Cited by 36 · see citing works
SIVMAC Vpx improves the transduction of dendritic cells with nonintegrative HIV-1-derived vectors
Berger, G., Goujon, C., Darlix, J. L., & Cimarelli, A. (2008) · Gene Therapy · doi:10.1038/gt.2008.128 · Cited by 36 · see citing works
Influence of DNA Delivery Method on Gene Targeting Frequencies in Human Cells
Yáñez‐Muñoz, R. J., & Porter, A. C. G. (1999) · Somatic Cell and Molecular Genetics · doi:10.1023/b:scam.0000007137.28557.73 · Cited by 33 · see citing works
Self-citationKatz, R. A., Mack, J. P. G., Merkel, G., Kulkosky, J., Ge, Z., Leis, J. P., & Skalka, A. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6741 · Cited by 32 · see citing works
Delelis, O., Petit, C., Leh, H., Mbemba, G., Mouscadet, J. F., & Sonigo, P. (2005) · Retrovirology · doi:10.1186/1742-4690-2-31 · Cited by 30 · see citing works
Stable Transduction of Primary Human Monocytes by Simian Lentiviral Vector PBj
Mühlebach, M. D., Wolfrum, N., Schüle, S., Tschulena, U., Sanzenbacher, R., Flory, E., Cichutek, K., & Schweizer, M. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.06.483 · Cited by 30 · see citing works
Hagino‐Yamagishi, K., Donehower, L. A., & VARMUS, H. E. (1987) · Journal of Virology · doi:10.1128/jvi.61.6.1964-1971.1987 · Cited by 29 · see citing works
The second chance story of HIV-1 DNA: Unintegrated? Not a problem!
Wu, Y. (2008) · Retrovirology · doi:10.1186/1742-4690-5-61 · Cited by 26 · see citing works
Li, S., Kimura, E., Fall, B., Reyes, M., Angello, J. C., Welikson, R. E., Hauschka, S. D., & Chamberlain, J. S. (2005) · Cited by 24 · see citing works
Targeted gene modification in mouse ES cells using integrase‐defective lentiviral vectors
Okada, Y., Ueshin, Y., Hasuwa, H., Takumi, K., Okabe, M., & Ikawa, M. (2009) · genesis · doi:10.1002/dvg.20469 · Cited by 23 · see citing works
Conditionally replicating lentiviral-hybrid episomal vectors for suicide gene therapy.
Vargas, J. J., Klotman, M., & Cara, A. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.06.015 · Cited by 17 · see citing works
A single-LTR HIV-1 vector optimized for functional genomics applications
Ma, H., & Kafri, T. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.04.012 · Cited by 13 · see citing works
Monomer and multimer covalently closed circular forms of Rous sarcoma virus DNA
Goubin, G., & Hill, M. (1979) · Journal of Virology · doi:10.1128/jvi.29.2.799-804.1979 · Cited by 12 · see citing works
(2008) · Molecular Therapy · doi:10.1016/s1525-0016(16)40310-2 · Cited by 2 · see citing works
(2007) · Molecular Therapy · doi:10.1016/s1525-0016(16)45195-6 · Cited by 1 · see citing works
(2007) · Molecular Therapy · doi:10.1016/s1525-0016(16)45213-5 · Cited by 1 · see citing works
878. Factor IX Expression from Non Integrating Lentiviral Vectors in Muscle
(2008) · Molecular Therapy · doi:10.1016/s1525-0016(16)40281-9 · Cited by 1 · see citing works
Flagged first, then by citations
1 of the 152 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954 · see citing works
Therapeutic in vivo delivery of gene editing agents
Raguram, A., Banskota, S., & Liu, D. R. (2022) · Cell · doi:10.1016/j.cell.2022.03.045 · Cited by 532 · see citing works
Current applications and future perspective of CRISPR/Cas9 gene editing in cancer
Wang, S.-W., Gao, C., Zheng, Y.-M., Yi, L., Lu, J.-C., Huang, X.-Y., Cai, J.-B., Zhang, P.-F., Cui, Y.-H., & Ke, A.-W. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01518-8 · Cited by 478 · see citing works
Recent Advances in Lentiviral Vector Development and Applications
Mátrai, J., Chuah, M., & VandenDriessche, T. (2010) · Molecular Therapy · doi:10.1038/mt.2009.319 · Cited by 349 · see citing works
Holkers, M., Maggio, I., Liu, J., Janssen, J. M., Miselli, F., Mussolino, C., Recchia, A., Cathomen, T., & Gonçalves, M. A. F. V. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1446 · Cited by 312 · see citing works
Engineered materials for in vivo delivery of genome-editing machinery
Tong, S., Moyo, B., Lee, C. M., Leong, K. W., & Bao, G. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0145-9 · Cited by 206 · see citing works
Engineered Viruses as Genome Editing Devices
Chen, X., & Gonçalves, M. A. F. V. (2015) · Molecular Therapy · doi:10.1038/mt.2015.164 · Cited by 151 · see citing works
Ortinski, P. I., O’Donovan, B., Dong, X., & Kantor, B. (2017) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.04.002 · Cited by 146 · see citing works
Adenoviral vector DNA for accurate genome editing with engineered nucleases
Holkers, M., Maggio, I., Henriques, S. F. D., Janssen, J. M., Cathomen, T., & Gonçalves, M. A. F. V. (2014) · Nature Methods · doi:10.1038/nmeth.3075 · Cited by 138 · see citing works
Transformation-associated recombination (TAR) cloning for genomics studies and synthetic biology
Kouprina, N., & Larionov, V. (2016) · Chromosoma · doi:10.1007/s00412-016-0588-3 · Cited by 127 · see citing works
Nonintegrating Gene Therapy Vectors
Athanasopoulos, T., Munye, M. M., & Yáñez‐Muñoz, R. J. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.06.007 · Cited by 128 · see citing works
Self-citationKhoshandam, M., Soltaninejad, H., Mousazadeh, M., Hamidieh, A. A., & Hosseinkhani, S. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.027 · Cited by 130 · see citing works
Lentiviral vectors, two decades later
Naldini, L., Trono, D., & Verma, I. M. (2016) · Science · doi:10.1126/science.aah6192 · Cited by 123 · see citing works
Clinical applications of retinal gene therapy
Lipinski, D. M., Thake, M., & MacLaren, R. E. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.09.001 · Cited by 122 · see citing works
Human Artificial Chromosomes for Gene Delivery and the Development of Animal Models
Kazuki, Y., & Oshimura, M. (2011) · Molecular Therapy · doi:10.1038/mt.2011.136 · Cited by 117 · see citing works
Emerging Gene Therapies for Genetic Hearing Loss
Ahmed, H., Shubina-Oleinik, O., & Holt, J. R. (2017) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-017-0634-8 · Cited by 104 · see citing works
Ocular gene delivery using lentiviral vectors
Balaggan, K. S., & Ali, R. R. (2011) · Gene Therapy · doi:10.1038/gt.2011.153 · Cited by 104 · see citing works
Kerzel, T., Giacca, G., Beretta, S., Bresesti, C., Notaro, M., Scotti, G. M., Balestrieri, C., Canu, T., Redegalli, M., Pedica, F., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.09.014 · Cited by 99 · see citing works
The Promise and the Hope of Gene Therapy
Papanikolaou, E., & Bosio, A. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.618346 · Cited by 62 · see citing works
Immunization delivered by lentiviral vectors for cancer and infectious diseases
Hu, B., Tai, A., & Wang, P. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00967.x · Cited by 85 · see citing works
Llana, O. C., Houghton, B. C., Rinaldi, F., Taylor, H., Yáñez‐Muñoz, R. J., Uney, J. B., Wong, L., & Caldwell, M. A. (2014) · Molecular Therapy · doi:10.1038/mt.2014.206 · Cited by 85 · see citing works
Self-citationZinc-Finger Nucleases for Somatic Gene Therapy: The Next Frontier
Rahman, S. H., Maeder, M. L., Joung, J. K., & Cathomen, T. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.087 · Cited by 78 · see citing works
A new generation of human artificial chromosomes for functional genomics and gene therapy
Kouprina, N., Earnshaw, W. C., Masumoto, H., & Larionov, V. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1113-3 · Cited by 74 · see citing works
Different Methods of Delivering CRISPR/Cas9 Into Cells
Chandrasekaran, A. P., Song, M., Kim, K.-S., & Ramakrishna, S. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.05.001 · Cited by 70 · see citing works
Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through
Gurumoorthy, N., Nordin, F., Tye, G. J., Wan Kamarul Zaman, W. S., & Ng, M. H. (2022) · Biomedicines · doi:10.3390/biomedicines10010107 · Cited by 69 · see citing works
Izmiryan, A., Ganier, C., Bovolenta, M., Schmitt, A., Mavilio, F., & Hovnanian, A. (2018) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2018.06.008 · Cited by 68 · see citing works
Use of HIV as a gene transfer vector.
Pluta, K. D., & Kacprzak, M. M. (2009) · Acta Biochimica Polonica · doi:10.18388/abp.2009_2490 · Cited by 68 · see citing works
Binley, K., Widdowson, P. S., Kelleher, M., de Belin, J., Loader, J., Ferrige, G., Carlucci, M., Esapa, M., Chipchase, D., Angell-Manning, D., et al. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.008 · Cited by 61 · see citing works
Human artificial chromosome-based gene delivery vectors for biomedicine and biotechnology
Kouprina, N., Tomilin, A. N., Masumoto, H., Earnshaw, W. C., & Larionov, V. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.882314 · Cited by 60 · see citing works
Design and potential of non-integrating lentiviral vectors
Shaw, A., & Cornetta, K. (2014) · Biomedicines · doi:10.3390/biomedicines2010014 · Cited by 60 · see citing works
LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives
Al-Allaf, F. A., Coutelle, C., Waddington, S. N., David, A. L., Harbottle, R. P., & Themis, M. (2010) · International Archives of Medicine · doi:10.1186/1755-7682-3-36 · Cited by 60 · see citing works
Merienne, N., Douce, J. L., Faivre, E., Déglon, N., & Bonvento, G. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00106 · Cited by 58 · see citing works
Wu, Y., Wan, X., Zhao, D., Chen, X., Wang, Y., Tang, X., Li, J., Li, S., Sun, X., Bi, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40655-6 · Cited by 58 · see citing works
Pelascini, L. P. L., Janssen, J. M., & Gonçalves, M. A. F. V. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.069 · Cited by 58 · see citing works
Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
Uchida, N., Drysdale, C. M., Nassehi, T., Gamer, J., Yapundich, M., DiNicola, J., Shibata, Y., Hinds, M., Gudmundsdottir, B., Haro-Mora, J. J., et al. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2021.02.022 · Cited by 55 · see citing works
Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles
Yu, K., Natanson, H., & Dunbar, C. E. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.107 · Cited by 54 · see citing works
Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease
Germino-Watnick, P., Hinds, M., Le, A., Chu, R., Liu, X., & Uchida, N. (2022) · Cells · doi:10.3390/cells11111843 · Cited by 59 · see citing works
Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect
Chuang, Y.-F., Phipps, A. J., Lin, F., Hecht, V. F. G., Hewitt, A. W., Wang, P., & Liu, G. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03725-2 · Cited by 53 · see citing works
Delivery systems of CRISPR/Cas9-based cancer gene therapy
Biagioni, A., Laurenzana, A., Margheri, F., Chillà, A., Fibbi, G., & Rosso, M. D. (2018) · Journal of Biological Engineering · doi:10.1186/s13036-018-0127-2 · Cited by 52 · see citing works
Janssen, J. M., Chen, X., Liu, J., & Gonçalves, M. A. F. V. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.02.009 · Cited by 50 · see citing works
Luo, B., Zhan, Y., Luo, M., Dong, H., Liu, J., Lin, Y., Zhang, J., Wang, G., Verhoeyen, E., Zhang, Y., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03187-1 · Cited by 49 · see citing works
A guide to the optogenetic regulation of endogenous molecules
Manoilov, K. Y., Verkhusha, V. V., & Shcherbakova, D. M. (2021) · Nature Methods · doi:10.1038/s41592-021-01240-1 · Cited by 51 · see citing works
Retroviral Vectors: Post Entry Events and Genomic Alterations
Nowrouzi, A., Glimm, H., Kalle, C. V., & Schmidt, M. (2011) · Viruses · doi:10.3390/v3050429 · Cited by 47 · see citing works
Retroviral Vectors for Gene Therapy
Maier, P., Kalle, C. V., & Laufs, S. (2010) · Future Microbiology · doi:10.2217/fmb.10.100 · Cited by 49 · see citing works
Histones Are Rapidly Loaded onto Unintegrated Retroviral DNAs Soon after Nuclear Entry
Wang, G. Z., Wang, Y., & Goff, S. P. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.10.009 · Cited by 47 · see citing works
Lentiviral vectors for ocular gene therapy
Arsenijevic, Y., Berger, A., Udry, F., & Kostic, C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081605 · Cited by 47 · see citing works
Gene therapy and editing: Novel potential treatments for neuronal channelopathies
Wykes, R. C., & Lignani, G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.029 · Cited by 48 · see citing works
Hu, B., Dai, B., & Wang, P. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.012 · Cited by 45 · see citing works
Suwanmanee, T., Hu, G., Gui, T., Bartholomae, C. C., Kutschera, I., Kalle, C. V., Schmidt, M., Monahan, P. E., & Kafri, T. (2013) · Molecular Therapy · doi:10.1038/mt.2013.188 · Cited by 44 · see citing works
Genotoxicity of retroviral hematopoietic stem cell gene therapy
Trobridge, G. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.562496 · Cited by 45 · see citing works
Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens
Gallinaro, A., Borghi, M., Bona, R., Grasso, F., Calzoletti, L., Palladino, L., Cecchetti, S., Vescio, M. F., Macchia, D., Morante, V., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00171 · Cited by 44 · see citing works
Targeted gene therapies: tools, applications, optimization
Humbert, O., Davis, L., & Maizels, N. (2012) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2012.658112 · Cited by 43 · see citing works
Song, M. (2017) · Biotechnology Progress · doi:10.1002/btpr.2484 · Cited by 43 · see citing works
Gene Therapy of ABCA4-Associated DiseasesPreprint
Auricchio, A., Trapani, I., & Allikmets, R. L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017301 · Cited by 41 · see citing works
Efficient gene expression from integration-deficient lentiviral vectors in the spinal cord
Peluffo, H., Foster, E., Ahmed, S. G., Lago, N., Hutson, T. H., Moon, L., Yip, P., Wanisch, K., Caraballo-Miralles, V, Olmos, G., et al. (2013) · Gene Therapy · doi:10.1038/gt.2012.78 · Cited by 40 · see citing works
Self-citationKumar, P., & Chan, W. (2011) · Current Gene Therapy · doi:10.2174/156652311794940782 · Cited by 40 · see citing works
Kymäläinen, H., Appelt, J. U., Giordano, F. A., Davies, A. F., Ogilvie, C. M., Ahmed, S., Laufs, S., Schmidt, M., Bode, J., Yáñez‐Muñoz, R. J., et al. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.172 · Cited by 38 · see citing works
Self-citationZhang, W., Hou, Y., Yin, S., Miao, Q., Lee, K., Zhou, X., & Wang, Y. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02580-8 · Cited by 43 · see citing works
Verghese, S. C., Goloviznina, N. A., Skinner, A. M., Lipps, H. J., & Kurre, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku082 · Cited by 37 · see citing works
Recent progress in lentiviral vector mass production
Ansorge, S., Henry, O., & Kamen, A. (2009) · Biochemical Engineering Journal · doi:10.1016/j.bej.2009.10.017 · Cited by 37 · see citing works
Kononenko, A. V., Bansal, R., Lee, N., Grimes, B. R., Masumoto, H., Earnshaw, W. C., Larionov, V., & Kouprina, N. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku870 · Cited by 36 · see citing works
Negri, D. R. M., Blasi, M., LaBranche, C. C., Parks, R., Balachandran, H., Lifton, M. A., Shen, X., Denny, T. N., Ferrari, G., Vescio, M. F., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.123 · Cited by 35 · see citing works
Negri, D. R. M., Bona, R., Michelini, Z., Leone, P., Macchia, I., Klotman, M. E., Salvatore, M., & Cara, A. (2010) · Human Gene Therapy · doi:10.1089/hum.2009.200 · Cited by 34 · see citing works
Chick, H. E., Nowrouzi, A., Fronza, R., McDonald, R. A., Kane, N. M., Alba, R., Delles, C., Sessa, W. C., Schmidt, M., Thrasher, A. J., et al. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.042 · Cited by 33 · see citing works
Manufacturing of viral vectors: part II. Downstream processing and safety aspects
Merten, O.-W., Schweizer, M., Chahal, P. S., & Kamen, A. (2014) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.14.15 · Cited by 33 · see citing works
Genetic engineering including superseding microinjection: new ways to make GM pigs
Galli, C., Perota, A., Brunetti, D., Lagutina, I., Lazzari, G., & Lucchini, F. (2010) · Xenotransplantation · doi:10.1111/j.1399-3089.2010.00590.x · Cited by 33 · see citing works
Coutant, F., Sanchez David, R. Y., Félix, T., Boulay, A., Caleechurn, L., Souque, P., Thouvenot, C., Bourgouin, C., Beignon, A.-S., & Charneau, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048644 · Cited by 32 · see citing works
Lentiviral vectors for immunization: an inflammatory field
Pincha, M., Sundarasetty, B. S., & Stripecke, R. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.9 · Cited by 32 · see citing works
Lentiviral Vectors: A Versatile Tool to Fight Cancer
Emeagi, P. U., Goyvaerts, C., Maenhout, S. K., Pen, J. J., Thielemans, K., & Breckpot, K. (2013) · Current Molecular Medicine · doi:10.2174/1566524011313040011 · Cited by 31 · see citing works
Lentiviral Vector-Mediated RNA Silencing in the Central Nervous System
Hutson, T. H., Foster, E., Moon, L. D. F., & Yáñez‐Muñoz, R. J. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.016 · Cited by 31 · see citing works
Self-citationIntegrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity
Negri, D. R. M., Michelini, Z., Bona, R., Blasi, M., Filati, P., Leone, P., Rossi, A., Franco, M., & Cara, A. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.571670 · Cited by 30 · see citing works
New Insights into the Therapeutic Applications of CRISPR/Cas9 Genome Editing in Breast Cancer
Ahmed, M., Daoud, G. H., Mohamed, A., & Harati, R. (2021) · Genes · doi:10.3390/genes12050723 · Cited by 30 · see citing works
Stable expression of large transgenes via the knock-in of an integrase-deficient lentivirus
Chavez, M., Rane, D. A., Chen, X., & Qi, L. S. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01037-x · Cited by 30 · see citing works
Gene and cell therapy based treatment strategies for inflammatory bowel diseases
van der Marel, S. (2011) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v2.i6.114 · Cited by 30 · see citing works
Jia, S., Liang, R., Chen, J., Liao, S., Lin, J., & Li, W. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00581-x · Cited by 32 · see citing works
Cockrell, A. S., van Praag, H., Santistevan, N. J., Ma, H., & Kafri, T. (2011) · Retrovirology · doi:10.1186/1742-4690-8-51 · Cited by 29 · see citing works
Kwilas, A. R., Yednak, M. A., Zhang, L., Liesman, R. M., Collins, P. L., Pickles, R. J., & Peeples, M. E. (2010) · Journal of Virology · doi:10.1128/jvi.00346-10 · Cited by 29 · see citing works
Gene Therapy for Inherited Hearing Loss: Updates and Remaining Challenges
Hahn, R., & Avraham, K. B. (2023) · Audiology Research · doi:10.3390/audiolres13060083 · Cited by 28 · see citing works
Gene Therapy to Improve Pancreatic Islet Transplantation for Type 1 Diabetes Mellitus
Hughes, A. H., Jessup, C. F., Drogemuller, C., Mohanasundaram, D., Milner, C. R., Rojas, D., Russ, G. R., & Coates, P. T. H. (2010) · Current Diabetes Reviews · doi:10.2174/157339910793360897 · Cited by 28 · see citing works
Yang, G., Si-Tayeb, K., Corbineau, S., Vernet, R., Gayon, R., Dianat, N., Martinet, C., Clay, D., Goulinet-Mainot, S., Tachdjian, G., et al. (2013) · BMC Biology · doi:10.1186/1741-7007-11-86 · Cited by 26 · see citing works
Therapeutic genome engineering via CRISPR ‐Cas systems
Moreno, A. M., & Mali, P. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1380 · Cited by 25 · see citing works
Lin, Y.-Y., Belle, I., Blasi, M., Huang, M.-N., Buckley, A. F., Rountree, W., Klotman, M. E., Cara, A., & Negri, D. R. M. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.03.008 · Cited by 26 · see citing works
Wen, B., Deng, Y. L., Chen, H., Guan, J., Chuai, X., Ruan, L., Kong, W., & Tan, W. (2013) · Molecular Therapy · doi:10.1038/mt.2013.122 · Cited by 26 · see citing works
Negri, D. R. M., Michelini, Z., Baroncelli, S., Spada, M., Vendetti, S., Bona, R., Leone, P., Klotman, M. E., & Cara, A. (2010) · BioMed Research International · doi:10.1155/2010/534501 · Cited by 24 · see citing works
Liu, J., & Shui, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.014 · Cited by 24 · see citing works
Knocking down schistosomes – promise for lentiviral transduction in parasites
Hagen, J., Scheerlinck, J. Y., & Gasser, R. B. (2015) · Trends in Parasitology · doi:10.1016/j.pt.2015.03.009 · Cited by 24 · see citing works
Advances of Genome Editing with CRISPR/Cas9 in Neurodegeneration: The Right Path towards Therapy
Klinkovskij, A., Shepelev, M. V., Isaakyan, Y. A., Aniskin, D., & Ulasov, I. V. (2023) · Biomedicines · doi:10.3390/biomedicines11123333 · Cited by 23 · see citing works
Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology
Sizemore, R. J., Seeger-Armbruster, S., Hughes, S. M., & Parr‐Brownlie, L. C. (2016) · Journal of Neurophysiology · doi:10.1152/jn.01131.2015 · Cited by 23 · see citing works
Focusing Brain Therapeutic Interventions in Space and Time for Parkinson’s Disease
Little, S. J., & Brown, P. (2014) · Current Biology · doi:10.1016/j.cub.2014.08.002 · Cited by 22 · see citing works
Snowball, A., & Schorge, S. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.05.004 · Cited by 22 · see citing works
Torres-Ruiz, R., Garcia, A. F. R., Jimenez, M., Rodriguez, S., & Ramı́rez, J. C. (2014) · Gene Therapy · doi:10.1038/gt.2014.1 · Cited by 22 · see citing works
Lu‐Nguyen, N., Broadstock, M., Schliesser, M. G., Bartholomae, C. C., Kalle, C. V., Schmidt, M., & Yáñez‐Muñoz, R. J. (2014) · Human Gene Therapy · doi:10.1089/hum.2014.003 · Cited by 22 · see citing works
Self-citationSimian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines
Negri, D. R. M., Rossi, A., Blasi, M., Michelini, Z., Leone, P., Chiantore, M. V., Baroncelli, S., Perretta, G., Cimarelli, A., Klotman, M. E., et al. (2012) · Retrovirology · doi:10.1186/1742-4690-9-69 · Cited by 22 · see citing works
Deng, Y., Guan, J., Wen, B., Zhu, N., Chen, H., Song, J., Yang, Y., Wang, Y., & Tan, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062684 · Cited by 21 · see citing works
Pelascini, L. P. L., Maggio, I., Liu, J., Holkers, M., Cathomen, T., & Gonçalves, M. A. F. V. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.107 · Cited by 21 · see citing works
Yang, Y., Li, J., Zou, Q., Ruan, Y., & Feng, H. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.10.018 · Cited by 20 · see citing works
Genetic Therapies for Hearing Loss: Accomplishments and Remaining Challenges
Taiber, S., & Avraham, K. B. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134527 · Cited by 20 · see citing works
Tang, N., Zhang, Y., Shen, Z., Yao, Y., & Nair, V. (2021) · The CRISPR Journal · doi:10.1089/crispr.2021.0017 · Cited by 20 · see citing works
Ahmed, S., Waddington, S. N., Boza-Moran, M.-G., & Yáñez‐Muñoz, R. J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.029 · Cited by 19 · see citing works
Self-citationKitawi, R. C., Ledger, S., Kelleher, A. D., & Ahlenstiel, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052771 · Cited by 18 · see citing works
- Authors
- Wanisch, K., & Yáñez-Muñoz, R. J.
- Affiliations
- University of London (GB)
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 17
- Issue
- 8
- Pages
- 1316-1332
- ISSN
- 1525-0016 (ISSN-L)
- PMC
- PMC2835240
- OpenAlex
- W1976244438
- Cited by
- 222
- References
- 152
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 10 · 2023: 12 · 2022: 12 · 2021: 15 · 2020: 4 · 2019: 8 · 2018: 10 · 2017: 13 · 2016: 14 · 2015: 13 · 2014: 22 · 2013: 19 · 2012: 18
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Therapy (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Keywords
- integrase mutations, proviral integration, insertional mutagenesis, quiescent cells, transient expression, stable transduction, homologous recombination, site-specific recombination, transposition, gene therapy
- MeSH terms
- Animals, Genetic Vectors, Humans, Mutation, Transduction, Genetic, Lentivirus, Integrases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review